Drug repositioning for personalized medicine

@inproceedings{Li2012DrugRF,
  title={Drug repositioning for personalized medicine},
  author={Yvonne Y. Li and Steven Jm Jones},
  booktitle={Genome Medicine},
  year={2012}
}
Human diseases can be caused by complex mechanisms involving aberrations in numerous proteins and pathways. With recent advances in genomics, elucidating the molecular basis of disease on a personalized level has become an attainable goal. In many cases, relevant molecular targets will be identified for which approved drugs already exist, and the potential repositioning of these drugs to a new indication can be investigated. Repositioning is an accelerated route for drug discovery because… CONTINUE READING

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 67 CITATIONS, ESTIMATED 80% COVERAGE

FILTER CITATIONS BY YEAR

2012
2019

CITATION STATISTICS

  • 2 Highly Influenced Citations

  • Averaged 10 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 127 REFERENCES

KRAS mutation detection: a new look at an old gene.

  • Clinical chemistry
  • 2010
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Crizotinib--latest champion in the cancer wars?

  • The New England journal of medicine
  • 2010
VIEW 11 EXCERPTS
HIGHLY INFLUENTIAL